asthma lung disease
Conditions
Interventions
None listed
Sponsors
Centre for Human Drug Research
Eligibility
Age
2 Years to 17 Years
Inclusion criteria
Inclusion criteria: 1. Signed informed consent from both parents prior to any study-mandated procedure. 2. Admission to the pediatric ward of Juliana Children*s Hospital, determined by the attending physician at the time of admission to be due to: a. Community acquired pneumonia or bronchiolitis (lower respiratory tract infection) (Age 2-12) b. Preschool wheezing (Age 2-6) c. Asthma exacerbation with a previous history of asthma (Age 6-12)
Exclusion criteria
Exclusion criteria: 1. (interstitial) Lung disease other than infection, asthma or preschool wheezing, cardiac disease, neuromuscular disease, diabetes or any other chronic condition that is associated with impaired activity level. 2. Children that have a mental or motor impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Physical activity level (step count) during admission, directly after admission and one month after admission. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Hours of sleep and sleep pattern - Mean heart rate during admission and at home, data collected via smartwatch - Daily temperature using Nokia Thermo (children with preschool wheezing and lower respiratory tract infection) - Daily FEV1/PEF/FVC measurements via portable spirometer (patients with asthma) - Daily questions / symptom scores via smartphone app: a. Asthma control diary (ACD) for patients with asthma b. Respiratory symptom scores for patients with pneumonia and bronchiolitis c. Medication use and activity estimation d. Parent-reported recovery - Proportion of patients with good compliance to study tasks, stratified by age- and disease groups. - End-of-study questionnaire for parents and children about the experience and tolerability of this method of data collection. | — |
Countries
Netherlands
Outcome results
None listed